Plasma is an ionized gas that is typically generated in high-temperature laboratory conditions. Recent progress in atmospheric plasmas leads to creation of cold plasmas with ion temperatures near room temperature.
1 Such plasmas constitute "cocktail" of various reactive species including reactive oxygen species (ROS) and reactive nitrogen species (RNS). Experimental evidence on the effectiveness of cold atmospheric plasma (CAP) applications for killing cancer cells and decreasing the tumor size provides a solid basis for its potential use in cancer treatment.
2,17 So far, CAP has been mainly used to kill cancer cells by the direct irradiation on cancer cells immersing in cell culture media. However, recently, the CAP stimulated media were found to be able to kill cancer cells as well as the direct CAP treatment did. 3, 4 In contrast to conventional direct CAP treatment, which is more like a surgical strategy, using the CAP stimulated media to kill cancer cells is promising to be a pharmaceutics method. Glioblastoma is the most lethal brain cancer. 5 The median survival time of patients under standard care is just 15 months. 5 Such low survival rate is due to the strong resistance of glioblastoma cells to conventional cancer treatment methods. 6 Recently, CAP demonstrated promise in the treatment of glioblastoma in vitro 4, 7 and in the delaying the growth of glioblastoma in animal model in vivo. 8 In this study, we investigated the factors affecting the killing capacity of CAP stimulated media on glioblastoma (U87) cells, which built the foundation for controlling the plasma stimulated media for the cancer treatment.
The CAP device used in described experiments is a typical cold plasma jet generator, which has been used in the previous research. 9 The detailed description of device is illustrated in Ref. 9 . The flow rate of helium gas was 5 l/min. The input voltage of DC power was 11.5 V. The plasma jet with a length of 3 cm vertically irradiated the media in a 96-well plate. Human U87 cells were provided by Dr. Murad Lab at the George Washington University. U87 cells were cultured for 1 day in a complete media composed of Dulbecco's modified Eagle's medium (DMEM) (Life Technologies) supplemented with 10% (v/v) fetal bovine serum (FBS) (Atlantic Biologicals) and 1% (v/v) antibiotic (penicillin and streptomycin) solution (Life Technologies) under the standard cell culture conditions (a humidified, 37 C, 5% CO 2 environment). U87 cells were seeded with a confluence of 24 000 cells/ml on a 96-well plate. Each well contained 100 ll of complete media.
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay (Sigma-Aldrich) was harnessed to assess the cell viability. After 1 day of culture, initial media were replaced by 100 ll of new media containing 0.7 mg/ml. After the subsequent culture of 3 h, the media were replaced by 100 ll of solvent (0.04% (v/v) hydrochloric acid in isopropanol). Ultimately, the absorbance of purple solution at 570 nm was measured using a microplate reader (Synergy H1 Microplate Reader, Hybrid Technology).
In this study, all protocols of control groups were identical to that of corresponding experimental groups, except that no CAP treatment was performed in control group. All data shown in figures are presented as the mean 6 standard deviation of three repeated experiments. For each experiment, the cell viability was presented as the relative viability by calculating the ratio of mean absorbance of experimental group (6 samples) and control group (6 samples). When the cancer cell viability is decreased after treatment, corresponding relative viability will be smaller than 1, vice versa.
Despite the CAP stimulated media has been proved to be effective as well as the direct CAP treatment, media was negligible, we just regulated the concentration of FBS in media. We performed CAP treatments on 100 ll of media in 96-well plate with distinct FBS volume concentration (0%, 10%, 20%, and 30%). The protocol is schematically illustrated in Fig. 1(a) . For the media with a specific FBS concentration, CAP treatment was carried out for 5 s, 10 s, 20 s, 30 s, and 60 s, respectively. Subsequently, 100 ll of CAP stimulated media was transferred and replaced the overnight media in the wells on another 96-well plate which had been seeded with U87 cells. Ultimately, U87 cells were cultured in 100 ll of the CAP stimulated media for 1 day and experienced MTT assay.
It is found that the killing capability of CAP stimulated media can be controlled by regulating the concentration of FBS in media. When media do not contain FBS, as shown in Fig. 1(b) , the killing capability of media increases as the treatment time extends. When media contain FBS, regardless of what the concentration of FBS is, the killing capability of media shows a similar time-dependent trend. As the treatment time increases, the killing capability of media declines initially and rises subsequently. Short CAP treatment actually increases the viability of cancer cells. Only the long (>20 s) plasma treatment will lead to a noticeable decline of cell viability. In addition, for a specific treatment longer than 10 s, the killing capability of media decreases as the concentration of FBS increases. In short, FBS in the stimulated media plays a protective role for U87 cells.
In order to investigate the role of FBS, we studied the component-dependent effect of the stimulated media. The protocols are illustrated in Fig. 2(a) . DMEM or FBS in wells were stimulated by CAP for 30 s and 60 s. Then, 50 ll of stimulated DMEM or FBS was transferred to a new well seeding with U87 cells. Because cells cannot survive in FBS without DMEM, the complete media were not moved when stimulated DMEM or FBS was added. Ultimately, U87 cells were cultured in 150 ll of hybrid media (50 ll of stimulated DMEM or FBS þ 100 ll of un-stimulated complete media) for 1 day and experienced MTT assay. It is found that DMEM and FBS in the CAP stimulated media play opposite roles in determining the final fate of U87 cells. As shown in Fig. 2(b) , only the stimulated DMEM kills U87 cells. The stimulated FBS actually enhances the viability of U87 cells more than unstimulated FBS does.
The opposite roles of DMEM and FBS in the stimulated media can illustrate the time-dependent effect. Because dose is calculated by multiplying the plasma discharge power density by the plasma treatment time, the time-dependent effect is essentially a dose-dependent effect. The dose-dependent killing capability of CAP treatment has been observed by other groups [10] [11] [12] and was attributed to a mechanism that low and high level intracellular ROS induced by CAP benefited cell growth and induced cell death, respectively. 11 However, as shown in Fig. 1(b) , such effect is likely due to the FBS in media. When the CAP treatment is short, for the media containing FBS, most of reactive species react with FBS in media. As a result, the remaining reactive species in media decrease. Meanwhile, the CAP stimulated FBS enhances the viability of cancer cells better than the unstimulated FBS does. For above two reasons, the media experiencing short CAP treatment will enhance the viability of cancer cells. When the treatment time increases, the remaining reactive species will accumulate to a high level and start to kill cancer cells. Thus, a noticeable cell death will merely appear after long CAP treatment.
From the pharmaceutical perspective, a stable stimulated media is indispensable. However, the gradual loss of anti-tumor effects of stimulated media has been found. 4 In this study, based on a series of time-lapse experiments, the instability of CAP stimulated media is found just due to the FBS in media. Specifically, the CAP treated DMEM or complete media (90% DMEM þ 10% FBS) were held for a period of time (1 h, 3 h, 6 h, and 9 h) under room temperature. Then, they were transferred to affect U87 cells seeded in 96-well plate. The protocols of CAP treatment were identical to that shown in Fig. 1(a) . Subsequently, U87 cells were cultured for 1 day and ultimately experienced MTT assay. As shown in Figs. 3(a) and 3(b) , the killing capacity of stimulated complete media decreases as the holding time increases. On the contrary, the killing capacity of stimulated DMEM retains stable. These trends are independent of the treatment time. This result demonstrates that the stability of stimulated media can be controlled by regulating the amount of FBS in media.
Because the main distinction between DMEM and complete media is the proteins in FBS, the reaction between reactive species and proteins in FBS may contribute to the instability of CAP stimulated complete media. It is under debating on which reactive species in CAP contribute to the death of cancer cells. DNA double-strands break (DDSB) and apoptosis have been commonly acknowledged to trigger the death of cancer cells in CAP treatment. 13 RNS is capable of inducing the death of cells via DDSB and apoptosis. On one hand, NO is able to easily penetrate the membranes of cells and organelles 14 and block the electron transport chain in mitochondria, which leads to the rise of ROS in mitochondria and ultimately trigger apoptosis by damaging mitochondria. 15 On the other hand, NO reacts with O 2 À generated in mitochondria to form peroxynitrite, which will attack nearly all important macromolecules in cells. 15 Thus, RNS in CAP may play key role triggering the death of cancer cells. Similar conclusion has been made by other group. 12, 18 To verify the above assumption, we investigated the nitrite (NO 2 À ) evolution in the stimulated media. NO 2 À is a primary breakdown product of NO in aqueous solution. The characterization of NO 2 À was achieved via using Griess Reagent (Promega), which has been used to qualify RNS. 12 In this study, after CAP treatment (30 s and 60 s), 50 ll of stimulated DMEM or complete media in wells were held for a period of time (1 h, 3 h, and 24 h) under room temperature and were ultimately tested by Griess Reagent, following the standard protocols provided by Promega. As shown in Fig.  4(a) , the NO 2 À concentration in the stimulated DMEM is stable. In contrast, as shown in Fig. 4(b) , the NO 2 À concentration in the stimulated complete media (90% DMEM þ 10% FBS) gradually increases. Such trend is independent of the treatment time. For particular treatment time, the input RNS from CAP should be identical to all cases. Thus, Fig. 4 demonstrates that a slow RNS consuming reaction occurs in the stimulated complete media, which can explain the instability of the stimulated media. In addition, the long half-life of NO in aqueous solution also matches the slow decaying speed of the stimulated complete media. Because of the reaction among NO and hemoglobin, the half-life of NO in vivo is very short (<1 s). 16 However, the half-life of NO in aqueous solution is up to several hours or even one day. 14 Freeze is commonly harnessed in the store of medicine and reagent. However, we discovered that freezing accelerated the decaying of stimulated DMEM effect. Specifically, after 60 s of CAP treatment, 100 ll of stimulated DMEM or complete media in wells were immediately frozen and held for a period of time (1 day and 2 day) at À20 C. Before they were transferred to affect U87 cells seeding on 96-well plates, frozen media naturally thaw at room temperature for 1 h. As a comparison, 100 ll of CAP (60 s) stimulated DMEM or complete media in wells were held for 1 day and 2 day at room temperature before they were transferred to affect U87 cells. The protocols of CAP treatment were identical to that shown in Fig. 1(a) . Subsequently, U87 cells were cultured for 1 day and ultimately experienced MTT assay. As shown in Fig. 5 , freeze selectively affects the killing capacity of stimulated media. For complete media, the freeze on stimulated media does not significantly vary the death of U87 cells. On the contrary, freeze on stimulated DMEM remarkably weakens the killing capacity of stimulated DMEM. In other words, freeze on stimulated DMEM significantly exhaust the reactive species in stimulated DMEM. Despite corresponding mechanism is unknown, the insensitivity of stimulated complete media to freeze might give clues. As shown in Fig. 4 , when the holding time is adequately long, the NO 2 À concentration of the stimulated complete media is always noticeably higher than that of stimulated DMEM. This phenomenon reveals that RNS in the stimulated complete media may tend to exist as NO 2 À group on proteins. On the contrary, RNS in the stimulated DMEM may tend to exist as reactive species in aqueous solution, such as NO. Freeze on the stimulated DMEM may accelerate the transition from NO to NO 2 À . One explanation is that freeze may increase the solubility of oxygen (O 2 ) in the stimulated DMEM and enhance the reaction between NO and O 2, because the solubility of gas in water is inversely proportional to the temperature of water.
In summary, our study demonstrates the feasibility of controlling the killing capability of CAP stimulated media on glioblastoma cells by regulating the concentration of FBS in media and the store temperature for stimulated media. FBS and DMEM in the stimulated media play opposite roles in determining the ultimate fate of glioblastoma cells. The more FBS in media, the few glioblastoma cells will be killed. The FBS in media not only contributes to the dosedependent effect of CAP treatment but also determines the instability of stimulated media. Furthermore, freeze accelerates the decaying of stimulated media. Freeze should be avoided in the storage of stimulated media.
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